AI assistant
MCCORMICK & CO INC — Director's Dealing 2022
Dec 8, 2022
30330_dirs_2022-12-08_5d6c8fad-1ef9-4974-8193-d18e1c7e1491.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MCCORMICK & CO INC (MKC)
CIK: 0000063754
Period of Report: 2022-12-01
Reporting Person: Piper Sarah (Chief Human Relations Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options - Right to Buy | $49.025 | 2027-03-28 | Common Stock - Voting (1724) | Direct | |
| Options- Right to Buy | $52.975 | 2028-03-27 | Common Stock - Voting (2464) | Direct | |
| Options - Right to Buy | $73.695 | 2029-03-27 | Common Stock - Voting (1818) | Direct | |
| Options - Right to Buy | $69.31 | 2030-04-01 | Common Stock - Voting (3770) | Direct | |
| Options - Right to Buy | $89.16 | 2031-03-31 | Common Stock - Voting (2179) | Direct | |
| Options - Right to Buy | $97.26 | 2032-03-30 | Common Stock - Voting (2711) | Direct | |
| Options - Right to Buy | $93.49 | 2030-11-30 | Common Stock - Voting (17032) | Direct | |
| Restricted Stock Units | $0 | 2023-04-01 | Common Stock - Voting (252) | Direct | |
| Restricted Stock Units | $0 | 2024-03-31 | Common Stock - Voting (309) | Direct | |
| Restricted Stock Units | $0 | 2025-03-30 | Common Stock - Voting (636) | Direct |
Footnotes
F1: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries.
F2: The option grant vests after the third anniversary date and is only exercisable if certain stock price performance requirements are met. The performance requirements are an increase in the common stock non-voting price of 60% for 1/3 of the options, an increase in the common stock non-voting price of 80% for 1/3 of the options, and an increase in the common stock non-voting price of 100% for 1/3 of the options, in each case within five years of the grant date. Both the vesting date and performance requirements must be met for the portion of the grant to become exercisable.
F3: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2021, March 15, 2022 and March 15, 2023.
F4: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2022, March 15, 2023 and March 15, 2024.
F5: The Restricted Stock Units vest in thirds over a three-year period beginning March 15, 2023, March 15, 2024 and March 15, 2025.